Showing results (561-570 of 604) with videos related to

Sort By:
Pageof 61
RMD Open|January 31, 2023
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled studyXiaomei Leng, Wei Lin, Shixue Liu, et al.
Arthritis Research & Therapy|March 28, 2023
The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLEYuxue Nie, Boyuan Sun, Xin He, et al.
Clinical Rheumatology|May 16, 2025
Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional studyMinhui Wang, Jiaxin Zhou, Feng Zhan, et al.
International Journal of Rheumatic Diseases|June 28, 2019
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trialPanpan Zhang, Yiyi Gong, Zheng Liu, et al.
The European Respiratory Journal|January 13, 2019
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort studyJunyan Qian, Mengtao Li, Xiao Zhang, et al.
Rheumatology (Oxford, England)|February 7, 2025
Comparison of the efficacy and safety of methotrexate injection and methotrexate tablets in active RALin Qiao, Jiankang Hu, Daming Ou, et al.
Clinical Rheumatology|June 29, 2021
Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO RegistryLixi Zhang, Huiyi Zhu, Pinting Yang, et al.
Microbiology Spectrum|May 9, 2023
Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional StudyLifan Zhang, Yanan Ma, Nan Jiang, et al.
The New England Journal of Medicine|December 25, 2015
Selexipag for the Treatment of Pulmonary Arterial HypertensionOlivier Sitbon, Richard Channick, Kelly M Chin, et al.
International Journal of Rheumatic Diseases|February 13, 2019
Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factorsNa Zhang, Mengtao Li, Junyan Qian, et al.
Pageof 61